Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
Earnings for Adverum Biotechnologies (ADVM)
Earnings in 2023 (TTM): -$0.12 B
According to Adverum Biotechnologies 's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.16 B a decrease over its 2021 earnings that were of -$0.15 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Adverum Biotechnologies from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.12 B | -23.45% |
| 2022 | -$0.16 B | 6.13% |
| 2021 | -$0.15 B | 25.04% |
| 2020 | -$0.12 B | 80.49% |
| 2019 | -$64.49 M | -12.71% |
| 2018 | -$73.88 M | 31.58% |
| 2017 | -$56.15 M | -50.97% |
| 2016 | -$0.12 B | 141.34% |
| 2015 | -$47.46 M | 86.79% |
| 2014 | -$25.41 M | 381.5% |
| 2013 | -$5.28 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -6.31% | 🇺🇸 USA |